COMMUNIQUÉS West-GlobeNewswire

Sanofi : La Cour d'appel ordonne un nouveau procès et annule l'injonction permanente dans le cadre du litige en cours relatif au brevet de Praluent® (alirocumab)

05/10/2017 - 18:29

La Cour d'appel ordonne un nouveau procès et annule l'injonction permanente dans le cadre du litige en cours relatif au brevet de Praluent ® (alirocumab) - Praluent continue d'être accessible aux patients aux États-Unis [...]

Sanofi : Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent® (alirocumab)

05/10/2017 - 18:29

Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent ® (alirocumab) - Praluent continues to be available to patients in the U.S. - Paris, France and Tarrytown, N. [...]

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 septembre 2017

05/10/2017 - 18:00

Nombre total de droits de vote et d'actions composant le capital social au 30 septembre 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, [...]

Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2017

05/10/2017 - 18:00

Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]

Summit Therapeutics plc : Exercise of Options

05/10/2017 - 17:25

Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 5 October 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing [...]

Final result of the voluntary offer for Weifa ASA

05/10/2017 - 17:00

Following final registration of acceptances, the final acceptance level in Karo Pharma AB's ("Karo Pharma") voluntary offer ("Voluntary Offer") to acquire all shares in Weifa ASA ("Weifa") is 35,463,139 shares [...]

Terveystalo Plc announces the early close of the Public Offering and the Personnel Offering due to oversubscription

05/10/2017 - 15:00

TERVEYSTALO PLC STOCK EXCHANGE RELEASE October 5, 2017 at 4:00 pm NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL [...]

Shire plc : Director/PDMR Shareholding

05/10/2017 - 13:00

Director/PDMR Shareholding October 5, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging [...]

Orion receives Lean Prize 2016

05/10/2017 - 11:35

ORION CORPORATION PRESS RELEASE 5 OCT 2017 at 12:35 EEST Orion receives Lean Prize 2016 As the cost pressures on pharmaceutical companies increase, Orion needs to constantly improve its efficiency to stay competitive. [...]

DRGT announces results of Phase I study expanding clinical utility of the drug Sirolimus utilizing the company's novel Super-API technology platform

05/10/2017 - 11:34

MSIDA, Malta, Oct. 05, 2017 (GLOBE NEWSWIRE) -- DRGT, a specialty pharmaceutical company, today announced the results of its Phase I study of DRGT18-2, a novel formulation of Sirolimus (Rapamune®), originally a Pfizer [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

05/10/2017 - 09:00

FIT Biotech Oy Company release October 5, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Solon Eiendom ASA : Primary insider notification

05/10/2017 - 08:30

(Oslo, Norway, 4 October 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 1 000 shares in Solon Eiendom ASA at a price of NOK 18,5000. Following this [...]

FIT Biotech Oy: FIT Biotech initiates gene therapy research collaboration with Avacta

05/10/2017 - 08:00

FIT Biotech Oy Company release 05.10.2017 at 9.00 EET FIT Biotech initiates gene therapy research collaboration with Avacta FIT Biotech Oy ("Company") today announced that it has initiated a research collaboration with [...]

MDxHealth Opens New Service and Research Laboratory in The Netherlands

05/10/2017 - 07:00

COMPANY ANNOUNCEMENT HERSTAL, BELGIUM - 07:00 CEST, October 5, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced the opening of its new service and research laboratory at the Novio Tech Campus in Nijmegen, the [...]

MDxHealth ouvre un nouveau laboratoire de service et de recherche aux Pays-Bas

05/10/2017 - 07:00

Annonce d'entreprise HERSTAL, BELGIQUE - 07:00 CEST, 5 octobre 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé l'ouverture de son nouveau laboratoire de service et de recherche, au Novio Tech Campus de Nimègue, aux [...]

TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting

05/10/2017 - 07:00

PRESS RELEASE TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting Leuven (BELGIUM) - October 5, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and [...]

TiGenix présentera les résultats favorables de la semaine 52 de l'essai de phase III de Cx601 à l'occasion du Congrès Mondial de Gastro-entérologie à ACG 2017

05/10/2017 - 07:00

COMMUNIQUÉ DE PRESSE TiGenix présentera les résultats favorables de la semaine 52 de l'essai de phase III de Cx601 à l'occasion du Congrès Mondial de Gastro-entérologie à ACG 2017 Louvain (BELGIQUE) - 5 octobre 2017, [...]

PCI Biotech receives US Orphan Drug Designation for fimaporfin in the treatment of bile duct cancer (cholangiocarcinoma)

04/10/2017 - 17:59

Oslo, 4 October 2017 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead product [...]

Abeona Therapeutics Announces Dedication of Commercial Gene Therapy Manufacturing Facility in Cleveland, Ohio

04/10/2017 - 14:51

-- Facility to support development of advanced gene and cell therapies for treatment of life-threatening rare diseases -- Leaders from local government, life sciences and medical technology to join on October 4 for [...]